Phytochemical Name : Torilis japonica extract (TJE)

Properties Information
PhytoCAT-ID PhytoCAT-1196
Phytochemical name or plant extracts Torilis japonica extract (TJE)
PMID 25051266
Literature evidence Torilis japonica extract, a new potential EMT suppressor agent by regulation of EGFR signaling pathways.
IUPAC name NA
Phytochemicals’ class or type of plant extracts Extract
Source of phytochemicals or plant Extracts Torilis japonica
Geographical availability Afghanistan, Albania, Assam, Austria, Baleares, Baltic States, Belarus, Belgium, Bulgaria, Central European Rus, China North-Central, China South-Central, China Southeast, Corse, Czechoslovakia, Denmark, East European Russia, East Himalaya, France, Germany, Great Britain, Greece, Hungary, Inner Mongolia, Iran, Ireland, Italy, Japan, Korea, Krym, Kuril Is., Myanmar, Nepal, Netherlands, North Caucasus, Northwest European R, Norway, Pakistan, Palestine, Poland, Portugal, Primorye, Romania, South European Russi, Spain, Sweden, Switzerland, Tibet, Transcaucasus, Turkey, Turkey-in-Europe, Ukraine, Vietnam, West Himalaya, Yugoslavia
Plant parts Whole Fruits
Other cancers Breast cancer
Target gene or protein EGFR, EMT
Gene or Protein evidence Using specific inhibitors and siEGFR, it was demonstrated that TJE suppressed EMT through EGFR inactivation and regulation of its downstream signaling pathways.
Target pathways TJE downregulates EGFR activation and both its downstream pathways, the Erk MAP kinase and Akt signaling pathways.
IC50 NA
Potency We suggest that TJE is a new potential reagent for EGFR-targeted therapy and anti-abnormal metastasis in MCF-7 breast cancer.
Cell line/ mice model MCF-7
Additional information  Also TJE treatment results in suppression of EGF-induced EMT by inducing the cell adherent related gene E-cadherin and decreasing mesenchymal markers with the E-cadherin suppressor gene.
PubChem ID NA
Additional PMIDs 9619115
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:849533-1
Safety NA